Therapeutic agents
US10414726B2 · kind B2 · utility
6Cited by
13References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 26, 2017 |
| Grant date | Sep 17, 2019 |
| Priority date | — |
| Expiry date | Sep 26, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of formula (I) or a compound of formula (II) or pharmaceutically acceptable salts thereof, wherein R1-R7 and X are as defined in the description, and the use of these compounds in therapy, in particular in treating cancer or as an inhibitor of the interaction of the MDM2 protein with p53.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.